A database of FDA approved therapeutic peptides and proteins
| ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1839 | Th1228 | Factor IX Complex (Human) | NA Full view | 0 | Ib | Hematological Disorders | AlphaNine SD or Mononine | Powder and solvent for solution for injection | Intravenous | Antihemophilic agent | NA | |
| 1843 | Th1231 | Ibritumomab tiuxetan | Heavy chain: QAYLQQS Full view | 652 | IIIc | Cancer | Zevalin | Spectrum Pharmaceuticals B.V. | Colourless Solution | Intravenous | Antibody, Immunosuppressive Agents | B-lymphocyte antigen CD20, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c |
| 1844 | Th1232 | Lenograstim | NA Full view | 0 | Ib | Immunological Disorders | Granocyte | NA | Solid | Subcutaneous or Intravenous | Antineoplastic and Immunomodulating Agents | Granulocyte colony-stimulating factor receptor |
| 1845 | Th1233 | Pegloticase | TYKKNDEVEFVRTGYGKDMI Full view | 298 | Ib | Osteological Disorders | Pegloticase (Krystexxa) | NA | Solid | Intravenous | Enzymes | Uric acid |
| 1846 | Th1234 | Protamine sulfate | NA Full view | 0 | Ib | Hematological Disorders | Protamine Sulfate Injection, USP | Omega Laboratories Ltd | off-white amorphous or crystalline powder | Intravenous | Heparin Antagonists, Hematologic Agents | NA |
| 1848 | Th1236 | Sipuleucel-T | NA Full view | 0 | IIIc | Cancer | Provenge | NA | Solution | Intravenous | Antineoplastic and Immunomodulating Agents | Prostatic acid phosphatase |
| 1851 | Th1238 | Susoctocog alfa | AIRRYYLGAVELSWDYRQSE Full view | 1448 | Ib | Hematological Disorders | Obizur | NA | Powder and solvent for solution for injection. | Intravenous | Blood coagulation factors, Antihaemorrhagics | von Willebrand factor |
| 1852 | Th1239 | Thrombomodulin Alfa | NA Full view | 0 | Ib | Hematological Disorders | Recomodulin (in Japan only) | Asahi Kasei Pharma Corp | lyophilized powder for solution | Intravenous | Anticoagulant agent, Antiplatelet agent | Prothrombin, Coagulation factor V |